{
    "clinical_study": {
        "@rank": "132809", 
        "arm_group": {
            "arm_group_label": "VytronUS Ablation System", 
            "arm_group_type": "Experimental", 
            "description": "Treatment with the VytronUS Ablation System."
        }, 
        "brief_summary": {
            "textblock": "The objective of this investigation is to evaluate whether pulmonary vein isolation using\n      the VytronUS ablation system is safe and effective acutely and at 3 months."
        }, 
        "brief_title": "A Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Paroxysmal Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 to 70 years old.\n\n          -  Recurrent symptomatic paroxysmal atrial fibrillation refractory to at least  one\n             antiarrhythmic drug.\n\n        Exclusion Criteria:\n\n          -  Prior pulmonary vein isolation\n\n          -  Presence of intracardiac thrombus\n\n          -  Indication of inaccessible pulmonary or cardiac anatomy\n\n          -  Myocardial infarction, PCI, or cardiac surgery in prior three months\n\n          -  Moderate to severe valvular disease or prior valve replacement\n\n          -  NYHA Class IV\n\n          -  LVEF < 40%\n\n          -  Previous stroke or TIA\n\n          -  Serum creatinine > 2.5mg/dL or allergy to intravenous contrast agents\n\n          -  Existing bleeding diathesis or history of complications with anticoagulation therapy\n\n          -  Women who are nursing, pregnant, or trying to become pregnant\n\n          -  Subjects unwilling or unable to provide consent\n\n          -  Participation in a drug or device trial that would prevent completion of required\n             study procedures\n\n          -  Active implantable devices\n\n          -  Major organ system disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01900678", 
            "org_study_id": "VLIC-USA", 
            "secondary_id": "CIV-13-04-010581"
        }, 
        "intervention": {
            "arm_group_label": "VytronUS Ablation System", 
            "description": "Pulmonary vein isolation.", 
            "intervention_name": "VytronUS Ablation System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "contact": {
                "email": "libor.machalek@homolka.cz", 
                "last_name": "Libor Machalek", 
                "phone": "+420 2 257 252 144"
            }, 
            "facility": {
                "address": {
                    "city": "Prague", 
                    "country": "Czech Republic"
                }, 
                "name": "Na Homolce Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Petr Neuzil, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Vivek Reddy, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Czech Republic"
        }, 
        "number_of_arms": "1", 
        "official_title": "VLIC-USA: A Single-Center Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System", 
        "overall_contact": {
            "email": "cschneider@vytronus.com", 
            "last_name": "Christopher Schneider", 
            "phone": "408-730-1333"
        }, 
        "overall_official": {
            "affiliation": "Na Homolce Hospital", 
            "last_name": "Petr Neuzil, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Czech Republic: State Institute for Drug Control", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Device or procedure related adverse events.", 
            "safety_issue": "Yes", 
            "time_frame": "Three months post procedure."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01900678"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Pulmonary vein isolation.", 
            "safety_issue": "No", 
            "time_frame": "Three months post procedure."
        }, 
        "source": "VytronUS, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "VytronUS, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}